Tissue microarray (TMA) block sections obtained from 232 patients with colorectal cancer were stained with IFITM1 antibody to correlate IFITM1 expression with survival rate and hazard ratio (Figure 7C–7E and Table 1). This evidence concerns the gene IFITM1 and colorectal cancer.